Selectis Health (GBCS) Capital Expenditures (2010 - 2025)

Selectis Health has reported Capital Expenditures for 16 years, with the latest figure at $56623.0 in Q4 2025.

• Quarterly Capital Expenditures rose 475.67% year-over-year to $56623.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $443611.0 (up 1130.1% YoY) and the FY2025 annual result came in at $443611.0, up 1130.1% from the prior year.
• Capital Expenditures improved to $56623.0 in Q4 2025 per GBCS's latest filing, from $4233.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $239679.0 in Q3 2022 and troughed at -$108408.0 in Q4 2022.
• A 5-year average of $65863.9 and a median of $42515.0 in 2023 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures plunged 518.79% in 2022, then jumped 766.61% in 2025.
• Over 5 years, Capital Expenditures stood at $25886.0 in 2021, then slumped by 518.79% to -$108408.0 in 2022, then soared by 101.77% to $1914.0 in 2023, then jumped by 413.9% to $9836.0 in 2024, then surged by 475.67% to $56623.0 in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered $56623.0, $4233.0, and $163515.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.